BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 12907315)

  • 1. Intrathecal nerve growth factor restores opioid effectiveness in an animal model of neuropathic pain.
    Cahill CM; Dray A; Coderre TJ
    Neuropharmacology; 2003 Sep; 45(4):543-52. PubMed ID: 12907315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tramadol has a better potency ratio relative to morphine in neuropathic than in nociceptive pain models.
    Christoph T; Kögel B; Strassburger W; Schug SA
    Drugs R D; 2007; 8(1):51-7. PubMed ID: 17249849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal NGF administration reduces reactive astrocytosis and changes neurotrophin receptors expression pattern in a rat model of neuropathic pain.
    Cirillo G; Cavaliere C; Bianco MR; De Simone A; Colangelo AM; Sellitti S; Alberghina L; Papa M
    Cell Mol Neurobiol; 2010 Jan; 30(1):51-62. PubMed ID: 19585233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
    Yamamoto T; Sakashita Y
    Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of spinal and systemic morphine on rat dorsal horn neuronal responses in the spinal nerve ligation model of neuropathic pain.
    Suzuki R; Chapman V; Dickenson AH
    Pain; 1999 Mar; 80(1-2):215-28. PubMed ID: 10204734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bidirectional Action of Cenicriviroc, a CCR2/CCR5 Antagonist, Results in Alleviation of Pain-Related Behaviors and Potentiation of Opioid Analgesia in Rats With Peripheral Neuropathy.
    Kwiatkowski K; Pawlik K; Ciapała K; Piotrowska A; Makuch W; Mika J
    Front Immunol; 2020; 11():615327. PubMed ID: 33408720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative actions of the opioid analgesics morphine, methadone and codeine in rat models of peripheral and central neuropathic pain.
    Erichsen HK; Hao JX; Xu XJ; Blackburn-Munro G
    Pain; 2005 Aug; 116(3):347-358. PubMed ID: 15982817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of spinal metabotropic glutamate receptor 1 (mGluR(1)) alleviates pain and restores opioid efficacy after nerve injury in rats.
    Fundytus ME; Yashpal K; Chabot JG; Osborne MG; Lefebvre CD; Dray A; Henry JL; Coderre TJ
    Br J Pharmacol; 2001 Jan; 132(1):354-67. PubMed ID: 11156596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.
    Wala EP; Sloan PA; Holtman JR
    J Opioid Manag; 2011; 7(5):377-89. PubMed ID: 22165037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lumbar transplant of neurons genetically modified to secrete brain-derived neurotrophic factor attenuates allodynia and hyperalgesia after sciatic nerve constriction.
    Cejas PJ; Martinez M; Karmally S; McKillop M; McKillop J; Plunkett JA; Oudega M; Eaton MJ
    Pain; 2000 May; 86(1-2):195-210. PubMed ID: 10779676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reorganization of dorsal root ganglion neurons following chronic sciatic nerve constriction injury: correlation with morphine and lidocaine analgesia.
    Kolesnikov Y; El-Maarouf A; Rutishauser U; Pasternak G
    Eur J Pharmacol; 2007 Jul; 568(1-3):124-33. PubMed ID: 17543299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats.
    Makuch W; Mika J; Rojewska E; Zychowska M; Przewlocka B
    Neuropharmacology; 2013 Dec; 75():445-57. PubMed ID: 24035921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy.
    Nichols ML; Lopez Y; Ossipov MH; Bian D; Porreca F
    Pain; 1997 Feb; 69(3):317-322. PubMed ID: 9085307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prolonged analgesic effect of epidural ropivacaine in a rat model of neuropathic pain.
    Sato C; Sakai A; Ikeda Y; Suzuki H; Sakamoto A
    Anesth Analg; 2008 Jan; 106(1):313-20, table of contents. PubMed ID: 18165597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.
    Wild KD; Bian D; Zhu D; Davis J; Bannon AW; Zhang TJ; Louis JC
    J Pharmacol Exp Ther; 2007 Jul; 322(1):282-7. PubMed ID: 17431136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal infusion of pyrrolidine dithiocarbamate for the prevention and reversal of neuropathic pain in rats using a sciatic chronic constriction injury model.
    Pan YD; Guo QL; Wang E; Ye Z; He ZH; Zou WY; Cheng ZG; Wang YJ
    Reg Anesth Pain Med; 2010; 35(3):231-7. PubMed ID: 20921832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethosuximide reduces allodynia and hyperalgesia and potentiates morphine effects in the chronic constriction injury model of neuropathic pain.
    Hamidi GA; Ramezani MH; Arani MN; Talaei SA; Mesdaghinia A; Banafshe HR
    Eur J Pharmacol; 2012 Jan; 674(2-3):260-4. PubMed ID: 22134003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral and histological effects of endoneurial administration of nerve growth factor: possible implications in neuropathic pain.
    Ruiz G; Ceballos D; Baños JE
    Brain Res; 2004 Jun; 1011(1):1-6. PubMed ID: 15140639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of intrathecal pertussis toxin animal model on the cellular mechanisms of neuropathic pain syndrome.
    Wen ZH; Chang YC; Wong CS
    Acta Anaesthesiol Sin; 2003 Dec; 41(4):187-96. PubMed ID: 14768516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with antiserum against dynorphin, substance P, or cholecystokinin enhances the morphine-produced anti-allodynia in the sciatic nerve ligated mice.
    Wu HE; Schwasinger ET; Hong JS; Tseng LF
    Neurosci Lett; 2005 Sep; 386(1):46-51. PubMed ID: 15982809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.